LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 79.34 | 84.90 | 933 | 9051 | 0.1031 | 0.4274 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 79.34 | 84.90 | 10536 | 9051 | 1.1640 | 1.0456 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 79.34 | 84.90 | 761 | 9051 | 0.0841 | 0.3848 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 79.34 | 84.90 | 10060 | 9051 | 1.1114 | 1.0316 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 81.05 | 84.90 | 908 | 8863 | 0.1024 | 0.4239 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 81.05 | 84.90 | 10780 | 8863 | 1.2162 | 1.0592 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 81.05 | 84.90 | 605 | 8863 | 0.0683 | 0.3402 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 81.05 | 84.90 | 10233 | 8863 | 1.1545 | 1.0433 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 82.75 | 84.90 | 829 | 8621 | 0.0962 | 0.4076 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 82.75 | 84.90 | 10920 | 8621 | 1.2666 | 1.0722 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 82.75 | 84.90 | 454 | 8621 | 0.0527 | 0.2860 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 82.75 | 84.90 | 10474 | 8621 | 1.2149 | 1.0593 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 84.45 | 84.90 | 844 | 8254 | 0.1022 | 0.4160 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 84.45 | 84.90 | 11192 | 8254 | 1.3558 | 1.0944 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 84.45 | 84.90 | 463 | 8254 | 0.0561 | 0.2929 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 84.45 | 84.90 | 10682 | 8254 | 1.2940 | 1.0796 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 86.16 | 84.90 | 863 | 8141 | 0.1060 | 0.4223 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 86.16 | 84.90 | 11374 | 8141 | 1.3970 | 1.1042 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 86.16 | 84.90 | 596 | 8141 | 0.0732 | 0.3445 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 86.16 | 84.90 | 10845 | 8141 | 1.3320 | 1.0890 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 87.86 | 84.90 | 836 | 7680 | 0.1089 | 0.4218 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 87.86 | 84.90 | 11560 | 7680 | 1.5051 | 1.1299 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 87.86 | 84.90 | 440 | 7680 | 0.0573 | 0.2881 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 87.86 | 84.90 | 11070 | 7680 | 1.4413 | 1.1157 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 89.57 | 84.90 | 828 | 7494 | 0.1105 | 0.4224 | MN20160318_Q02 | L17 |